Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA: Out-Of-Spec Components May Be Used In Finished Devices – But Beware

This article was originally published in The Gray Sheet

Executive Summary

In our first "Quality Replay" feature, we look back at an educational article from August 2010: Device firms frequently adjust manufacturing processes to accommodate components that are out of specification, but that isn’t necessarily a problem as long as the product meets “finished device specifications and all of its labeling requirements,” FDA's Jan Welch says. During an agency inspection, FDA will check to see whether a firm’s manufacturing change is a one-time exception or if the company makes changes on a regular basis. “The occasional one-off situation for a component or material may be acceptable with justification,” Welch explains. A company will typically consider the type of component, its risk of possible failure and whether it’s critical to the proper functioning of the device when deciding whether to use out-of-specification components.



Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts